When two drugs are repackaged as a combo drug, side effect risks soar
October 19, 2011 – I thought of that hilarious parody while reading about the newest FDA drug approval, which is not hilarious at all. The drug has a catchy name: Juvisync. It combines the statin Zocor with Januvia, a type 2 diabetes drug. So is it a cholesterol drug that controls blood sugar, or... Read More >


